title: Pre-exposure prophylaxis for infants exposed to HIV through breast feeding.
authors.affiliation: Pathogenesis and Control of Chronic Infections, UMR 1058 INSERM, University of Montpellier, France p-van_de_perre@chu-montpellier.fr.|CHU Montpellier, Montpellier, France.
authors.forename: Philippe
authors.initials: P
authors.lastname: Van de Perre
authors.affiliation: Department of Paediatrics and Child Health, University Teaching Hospital, Lusaka, Zambia.
authors.forename: Chipepo
authors.initials: C
authors.lastname: Kankasa
authors.affiliation: Pathogenesis and Control of Chronic Infections, UMR 1058 INSERM, University of Montpellier, France.|CHU Montpellier, Montpellier, France.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Nagot
authors.affiliation: Centre Muraz, Bobo-Dioulasso, Burkina Faso.|Centre of International Research for Health, Faculty of Health Sciences, University of Ouagadougou, Ouagadougou, Burkina Faso.
authors.forename: Nicolas
authors.initials: N
authors.lastname: Meda
authors.affiliation: Department of Paediatrics and Child Health, College of Health Sciences, Makerere University, Kampala, Uganda.
authors.forename: James K
authors.initials: JK
authors.lastname: Tumwine
authors.affiliation: Department of Paediatrics and Child Health, University of KwaZulu-Natal, Durban, South Africa.
authors.forename: Anna
authors.initials: A
authors.lastname: Coutsoudis
authors.affiliation: Centre for International Health, University of Bergen, Bergen, Norway.
authors.forename: Thorkild
authors.initials: T
authors.lastname: Tylleskär
authors.affiliation: Match Health Systems, School of Public Health, University of the Witwatersrand, South Africa.
authors.forename: Hoosen
authors.initials: H
authors.lastname: Coovadia
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D001942:Breast Feeding; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D018445:Infectious Disease Transmission, Vertical / Q000517:prevention & control*; D019259:Lamivudine / Q000627:therapeutic use*; D065129:Pre-Exposure Prophylaxis / Q000379:methods*
chemical_list: D019380:Anti-HIV Agents; D019259:Lamivudine